Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness-Reference-Cited by-同舟云学术

Lobeglitazone, a Novel Thiazolidinedione, Improves Non-Alcoholic Fatty Liver Disease in Type 2 Diabetes: Its Efficacy and Predictive Factors Related to Responsiveness

Published:2017 Issue:1 Volume:32 Page:60
ISSN:1011-8934
Container-title:Journal of Korean Medical Science
language:en
Short-container-title:J Korean Med Sci

Author:

Lee Yong-ho¹^ORCID,Kim Jae Hyeon²^ORCID,Kim So Ra¹^ORCID,Jin Heung Yong³^ORCID,Rhee Eun-Jung⁴^ORCID,Cho Young Min⁵^ORCID,Lee Byung-Wan¹^ORCID

Affiliation:

1. Department of Internal Medicine, Yonsei University College of Medicine, Seoul, Korea.

2. Division of Endocrinology and Metabolism, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.

3. Division of Endocrinology and Metabolism, Department of Internal Medicine, Research Institute of Clinical Medicine, Chonbuk National University Hospital, Chonbuk National University Medical School, Jeonju, Korea.

4. Division of Endocrinology and Metabolism, Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Korea.

5. Division of Endocrinology and Metabolism, Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.

Funder

Chong Keun Dang, Pharmaceutical Co.

Publisher

Korean Academy of Medical Sciences

Subject

General Medicine

Link

https://synapse.koreamed.org/pdf/10.3346/jkms.2017.32.1.60

Cited by 83 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of PPAR Ligands and Nanoparticle Technology in Metabolic Steatohepatitis Treatment;Biomedicines;2024-08-16

2. Effect of essential phospholipids on hepatic steatosis in metabolic dysfunction-associated steatotic liver disease associated with type 2 diabetes mellitus and/or hyperlipidemia and/or obesity: study protocol of a randomized, double-blind, phase IV clinical trial;Trials;2024-06-11

3. Roles and Mechanisms of Choline Metabolism in Nonalcoholic Fatty Liver Disease and Cancers;Frontiers in Bioscience-Landmark;2024-05-11

4. A comprehensive review on combination of lobeglitazone and glimepiride in management of type 2 diabetes mellitus;National Journal of Pharmacology and Therapeutics;2024-01

5. Lobeglitazone and Its Therapeutic Benefits: A Review;Cureus;2023-12-06